Xtant Medical Holdings, Inc. (XTNT)

Xtant Medical Holdings Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Net Income	0.66	-8.49	-4.85	-7.02	-8.22
Depreciation & Amortization	3.17	1.29	1.33	2.08	3.14
Share-Based Compensation	2.74	2.46	2.21	1.08	0.52
Other Operating Activities	-16.09	-0.61	1.75	3.13	4.15
Operating Cash Flow	-9.52	-5.34	0.44	-0.73	-0.41
Capital Expenditures	-1.28	-1.56	-1.89	-1.3	-0.54
Acquisitions	-23.5	0	0	0	0
Investing Cash Flow	-24.78	-1.56	-1.89	-1.3	-0.54
Share Issuance / Repurchase	14.01	9.31	18.43	0.67	0
Debt Issued / Paid	5.94	-0.29	-0.59	-0.47	-0.6
Other Financing Activities	-0.26	-	-0.34	-1.06	-
Financing Cash Flow	19.69	9.02	17.5	-0.86	-0.6
Exchange Rate Effect	0.02	0	0	0	0
Net Cash Flow	-14.58	2.12	16.05	-2.9	-1.56
Free Cash Flow	-10.8	-6.9	-1.45	-2.04	-0.96
Free Cash Flow Margin	-11.82%	-11.90%	-2.63%	-3.82%	-1.48%
Free Cash Flow Per Share	-0.09	-0.07	-0.02	-0.07	-0.07

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).